Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow

Céline Mazzotti (1) , Laure Buisson (1) , Sabrina Mahéo (1) , Aurore Perrot (2) , Marie-Lorraine Chrétien (3) , Xavier Leleu (4) , Cyrille Hulin (5) , Salomon Manier (6) , Benjamin Hebraud (7) , Murielle Roussel (7) , Laura Do Souto (7) , Michel Attal (7) , Hervé Avet-Loiseau (7) , Jill Corre (7)

1 CRCT - Centre de Recherches en Cancérologie de Toulouse
2 Service d'Hématologie [CHRU Nancy]
3 Service d'Hématologie Clinique (CHU de Dijon)
4 Service d'Hématologie [CHU Poitiers]
5 Service d'Hématologie [Bordeaux]
6 Service d'Hématologie [CHU Huriez Lille]
7 IUCT Oncopole - UMR 1037 - Institut Universitaire du Cancer de Toulouse - Oncopole

Domaines: Cancer

Céline Mazzotti, Laure Buisson, Sabrina Mahéo, Aurore Perrot, Marie-Lorraine Chrétien, et al.. Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow. Blood Advances, 2018, 2 (21), pp.2811 - 2813. ⟨10.1182/bloodadvances.2018025197⟩. ⟨hal-01919042⟩